Health and
Welfare Benefits

As a privileged partner of APPA (the Hospital Medical Practitioners Association), Bessé has been assisting hospital medical practitioners for nearly 40 years now by designing and handling their welfare benefit schemes.

Our partnership with the vast majority of hospitals all over France provides us with unique legitimacy and know-how, which we devote to the 40 000 interns and 55 000 hospital and assimilated medical practitioners who look after patients in France every day.

Find out more about APPA

For many years now, pharmaceutical companies have been confronted with multiple challenges, such as pioneering and the cost of innovation, while the development of generic medicines and pressure on prices have eaten away at margins, but also challenges arising from emerging countries, the reduction of environmental impact, etc..
These shifts have obviously had a huge impact on the staff involved in a sector that has undergone major mergers and acquisitions.
In the particular area of supplementary health and welfare benefits, the pharmaceutical industry’s National Collective Bargaining Agreement is one of the branches with the most specificities, requiring skilled know-how.
We have been operating in this sector for several decades now, providing assistance and guidance to companies of all sizes, in both local and international contexts.

We advise a large number of industrial groups in the nuclear sector.  In the field of nuclear medicine, we advise several companies, in particular one which has operations in Europe and in the United States and develops diagnostic and therapeutic products for nuclear molecular medicine.

We shall therefore continue to invest heavily in this specific field by providing those involved with tailored assistance, not only when it comes to the risks associated with their activities but also with health and welfare benefits for their team members.